Amrith Kumar

Amrith Kumar is a technologist and entrepreneur who has helped design, architect and create enterprise class software and hardware products. He is the co-founder of the Boston Big Data Summit and writes a blog, Hype Cycles, which discusses a variety of technology related subjects.

Recent posts

A Report from Boston’s First “Big Data Summit”
The first meeting of the Boston Big Data Summit was held yesterday. Since the announcement on October 2, the event has had a great reception. Just over a hundred people attended,... Read more »
Legislators Hear Testimony on Non-Compete Restrictions
Today marked a milestone in the legislation relating to non-competes in Massachusetts. The Joint Committee on Labor and Workforce Development held its public hearing on two house bills that would attempt... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More

FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts

BioIntelliSense Debuts "Sticker” Sensor to Capture Patient Data Remotely

Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

Disarm Therapeutics Names Scott Holmes Chief Financial Officer

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Xcelerating Life Sciences San Diego

Xcelerating Life Sciences Philadelphia

Xcelerating Life Sciences San Francisco

Amrith Kumar

Recent posts

A Report from Boston’s First “Big Data Summit”

Legislators Hear Testimony on Non-Compete Restrictions

Underwriters and Partners

What’s Next in Neuroscience Therapies

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

How to Approach Life Sciences Fundraising

Xconomy on Demand

We offer a number of ways to subscribe for free!